INUS
Straddle Chart

Markets / Mutual funds / Equity ETFs

Mutual fundsSIF

Axis NIFTY Healthcare ETF - Regular Plan - Growth

NAVs of 8 Nov 2026

Axis Mutual Fund · Index & ETFs fund · Regular plan · Growth

Equity ETFsRegular · GrowthRisk: Very High
NAV · 6 Nov 2026
₹172.2403 ▲ 0.67%
Axis Mutual Fund
Fund size₹23.98 crJuly - September 2026
1-month range₹156.55 – 172.24
1 year+15.37%rank 5 of 53
Expense ratio0.44%regular plan, a year
5 years+14.82%a year

What the fund does

The investment objective of the Scheme is to provide returns before expenses that closely correspond to the total returns of the NIFTY Healthcare Index subject to tracking errors. However, there is no assurance or guarantee that the investment objective of the scheme will be achieved.

BenchmarkNIFTY Healthcare TRI
Launched17 May 2021
Fund houseAxis Mutual Fund
Fund managersNandik MalikRohit Gautam

NAV history

157165172 2026-08-122026-08-252026-09-072026-09-212026-10-052026-10-162026-10-30

Returns

1 week
+2.92%avg 6.2%
1 month
+5.40%avg 5.8%
3 months
+1.24%avg -1.1%
6 months
+9.92%avg -0.5%
This year
+15.83%avg -3.3%
1 year
+15.37%avg -0.9% · #5/53
3 years (a year)
+21.66%avg 10.5% · #5/35
5 years (a year)
+14.82%avg -4.5% · #3/23

Bars: this plan; the thin mark is the Equity ETFs average (regular plans, growth option). Over a year: yearly averages (CAGR). Past returns do not guarantee future returns. Information only, not investment advice.

Monthly returns (%)

YearJanFebMarAprMayJunJulAugSepOctNovDec
2024+4.0
2025-6.2-7.9+7.8+1.1+0.4+3.8+3.2-3.3-1.4+3.8+2.3-2.6
2026-5.1+7.2-4.5+5.0+3.2+4.9+4.0+1.1-4.8+1.9+2.9

Each month's change in NAV (the current month to the latest NAV).

What if you had invested?

Worked out from this plan's actual NAVs. SIP: invested on the first NAV of each month. Taxes and exit loads are not included. Past returns do not guarantee future returns. Information only, not investment advice.

Portfolio as on 30 Sept 2026

Stocks held2022 lines in all
Top 10 stocks75.8%of the fund
Short positions-0.3%sold through derivatives
Net equity99.7%long stocks and derivatives minus shorts

Where the money is

Equity 100.0%Short -0.3%

Sectors (stocks held)

Pharmaceuticals & Biotechnology
81.1%
Healthcare Services
18.9%

Changes since 31 Aug 2026

Share of fund30 Sept 202631 Aug 2026Change
Stocks held100.0%100.0%0.00
Short positions-0.3%-0.1%-0.24
Cash & others0.0%0.0%+0.03
Top 10 stocks75.8%77.3%-1.48
Number of stocks20200
New stocks 2
  • Gland Pharma Limited2.04%
  • Krishna Institute Of Medical Sciences Limited1.76%
Stocks sold off 2
  • Piramal Pharma Limitedwas 1.15%
  • Syngene International Limitedwas 0.66%
Bought more 2
  • Dr. Reddy's Laboratories Limited+0.60
  • Laurus Labs Limited+0.41
Cut back 5
  • Sun Pharmaceutical Industries Limited-1.08
  • Max Healthcare Institute Limited-0.55
  • Fortis Healthcare Limited-0.52
  • Apollo Hospitals Enterprise Limited-0.45
  • Biocon Limited-0.25

Change is in percentage points. Bought more and cut back list stocks whose share of the fund moved by at least 0.25 points. A share can also move because the price changed, not only because the fund traded.

Stocks held 20

HoldingSector / type% of fund
Sun Pharmaceutical Industries Limited
INE044A01036		Pharmaceuticals & Biotechnology17.00%
Divi's Laboratories Limited
INE361B01024		Pharmaceuticals & Biotechnology10.44%
Apollo Hospitals Enterprise Limited
INE437A01024		Healthcare Services7.43%
Laurus Labs Limited
INE947Q01028		Pharmaceuticals & Biotechnology6.82%
Cipla Limited
INE059A01026		Pharmaceuticals & Biotechnology6.69%
Dr. Reddy's Laboratories Limited
INE089A01031		Pharmaceuticals & Biotechnology6.65%
Torrent Pharmaceuticals Limited
INE685A01028		Pharmaceuticals & Biotechnology6.24%
Max Healthcare Institute Limited
INE027H01010		Healthcare Services6.12%
Lupin Limited
INE326A01037		Pharmaceuticals & Biotechnology4.36%
Aurobindo Pharma Limited
INE406A01037		Pharmaceuticals & Biotechnology4.08%
Fortis Healthcare Limited
INE061F01013		Healthcare Services3.55%
Glenmark Pharmaceuticals Limited
INE935A01035		Pharmaceuticals & Biotechnology3.11%
Alkem Laboratories Limited
INE540L01014		Pharmaceuticals & Biotechnology2.75%
Zydus Lifesciences Limited
INE010B01027		Pharmaceuticals & Biotechnology2.54%
Mankind Pharma Limited
INE634S01028		Pharmaceuticals & Biotechnology2.51%
IPCA Laboratories Limited
INE571A01038		Pharmaceuticals & Biotechnology2.37%
Biocon Limited
INE376G01013		Pharmaceuticals & Biotechnology2.28%
Gland Pharma Limited
INE068V01023		Pharmaceuticals & Biotechnology2.04%
Krishna Institute Of Medical Sciences Limited
INE967H01025		Healthcare Services1.76%
Abbott India Limited
INE358A01014		Pharmaceuticals & Biotechnology1.25%

Short positions 1

HoldingSector / type% of fund
Net Receivables / (Payables)–-0.29%

Debt, money market and cash 1

HoldingSector / type% of fund
Clearing Corporation of India Ltd–0.32%

From the fund house's monthly portfolio (axismf.com), as on 30 Sept 2026. Percentages are of the fund's net assets; short positions are negative. Published about ten days after each month ends.

Risk

Volatility14.0%yearly, from daily NAVs
Worst fall-17.89%31 Aug 2021 → 30 Jun 2022
RiskometerVery HighVery High

Volatility: how much the NAV moves, as a yearly figure (higher = bumpier). Worst fall: the biggest drop from a high, in the NAV history we hold (from 31 May 2021).

Fund details

Fund size (average AUM, July - September 2026)₹23.98 cr across all plans
Fund houseAxis Mutual Fund
CategoryIndex & ETFs · Equity ETFs
PlanRegular
OptionGrowth
Expense ratio (TER)Direct 0.00% · Regular 0.44% (5 Nov 2026)
Exit loadN/A
Minimum investment50000 (Units) · additional 50000 (Units)
Scheme code (AMFI)148934
ISININF846K01Z12
NAV date6 Nov 2026

Scheme details from the fund's scheme summary document filed with AMFI; expense ratios from AMFI's daily filings.

Top Equity ETFs funds (regular plans)

Fund1 year3 years (a year)
Aditya Birla Sun Life Silver ETF+23.71%+36.26%
Aditya Birla Sun Life Gold ETF+16.60%+31.11%
Mirae Asset S&P 500 Top 50 ETF+6.40%+24.51%
Aditya Birla Sun Life Nifty Healthcare ETF+15.57%+22.07%
Axis NIFTY Healthcare ETF+15.37%+21.66%
Mirae Asset Nifty India Manufacturing ETF+5.35%+18.67%
Aditya Birla Sun Life Nifty Next 50 ETF+4.34%+17.83%
UTI - Nifty Next 50 Exchange Traded Fund+4.32%+17.82%

All Equity ETFs funds ranked › · Compare with others ›

← All mutual funds

Information only, not investment advice.

What is the NAV of Axis NIFTY Healthcare ETF - Regular Plan - Growth today?

₹172.2403 as of 6 Nov 2026, from AMFI's official NAV data.

What are the returns of Axis NIFTY Healthcare ETF - Regular Plan - Growth?

1 year: 15.37%, 3 years: 21.66% a year, 5 years: 14.82% a year

How does Axis NIFTY Healthcare ETF rank in its category?

5 of 53 Equity ETFs funds (regular plans, growth option) by 1-year return.

What is the difference between direct and regular plans?

Both invest in the same portfolio. Direct plans are bought straight from the fund house and pay no distributor commission, so their expenses are lower and their NAV grows slightly faster.